A Three-microRNA Signature as a Diagnostic and Prognostic Marker in Clear Cell Renal Cancer: An in Silico Analysis

PLoS ONE - United States
doi 10.1371/journal.pone.0180660
Full Text
Abstract

Available in full text

Date
Authors
Publisher

Public Library of Science (PLoS)

Related search

Diagnostic and Prognostic Value of CEP55 in Clear Cell Renal Cell Carcinoma as Determined by Bioinformatics Analysis

Molecular Medicine Reports
OncologyGeneticsMolecular BiologyBiochemistryCancer ResearchMolecular Medicine
2019English

Serum Pleiotrophin as a Diagnostic and Prognostic Marker for Small Cell Lung Cancer

Journal of Cellular and Molecular Medicine
Molecular MedicineCell Biology
2019English

MicroRNA-153 Acts as a Prognostic Marker in Gastric Cancer and Its Role in Cell Migration And invasion

OncoTargets and Therapy
OncologyPharmacology
2015English

A Nomogram Based on 9-lncRNAs Signature for Improving Prognostic Prediction of Clear Cell Renal Cell Carcinoma

Cancer Cell International
Cancer ResearchOncologyGenetics
2019English

Development and Validation of a Robust Multigene Signature as an Aid to Predict Early Relapse in Stage I-Iii Clear Cell and Papillary Renal Cell Cancer

Journal of Cancer
Oncology
2020English

SNPing Cancer in the Bud: MicroRNA and microRNA-target Site Polymorphisms as Diagnostic and Prognostic Biomarkers in Cancer

Pharmacology and Therapeutics
Pharmacology
2013English

Prognostic Impact of Immune Gene Expression Signature and Tumor Infiltrating Immune Cells in Localized Clear Cell Renal Cell Carcinoma

Journal for ImmunoTherapy of Cancer
OncologyMolecular MedicinePharmacologyCancer ResearchAllergyImmunology
2019English

Publisher Correction: Renal Capsular Invasion Is a Prognostic Biomarker in Localized Clear Cell Renal Cell Carcinoma

Scientific Reports
Multidisciplinary
2018English

MicroRNA-21 as a Diagnostic Marker for Hepatocellular Carcinoma: A Systematic Review and Meta-Analysis

Pakistan Journal of Medical Sciences
Medicine
2019English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy